Episode 20 - Conversations in Relapsed/Refractory Multiple Myeloma: Strategies to Effectively Introduce, Optimize, and Sequence Bispecific Antibody Therapy - Part 2: Insights into Use of Bispecific Antibodies and Recent Evidence
Practice Point®: Hematology por Practice Point Communications
Notas del episodio
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC/ACPE podcasts summarize the rationale/mechanism of action and clinical evidence on approved and emerging bispecific antibody therapy in RRMM and aid participants in using these agents safely by using clinical vignettes. The activity also provides guidance on early recognition of key adverse events and strategies to manage them, to ultimately improve outcomes for patients with RRMM.
Launch Date: May 2, 2024
Release Date: May 2, 2024
Expiration Date: April 30, 2025
FACULTY BIO
Jesús G. Berdeja, MD
Director of Multiple Myeloma Research
The Greco-Hainsworth Tennessee Oncology Centers for Research
Joseph Mikhael, MD, MEd, FRCPC, FAC ...